MarketInOut Stock Screener Log In | Sign Up

Beximco Pharmaceuticals Plc Gdr

LSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 08:00
Beximco Pharmaceuticals Plc Gdr stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeLSE
Market Capitalization234.21 mln
Float312 mln
Earnings Date02/02/2027

EPS

12.21
Robust

P / E

4.10
Deeply undervalued

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-2.62
Likely reliable

Relative Strength

35 / 100
Underperforming

Debt / Equity

0.05
Debt-free

Business Description

Founded in 1976 and based in Dhaka, Bangladesh, Beximco Pharmaceuticals develops and sells a broad range of medicines both at home and abroad. Its product lineup covers treatments for dozens of health conditions, from heart disease and diabetes to infections and cancer, available in many different forms such as tablets, creams, inhalers, and injectable fluids. The company also produces drug ingredients and manufactures medicines on behalf of other pharmaceutical businesses.

Key Fundamentals

EPS12.21
P/E4.10
ROE15.57
RPS0.73
ROIC13.03
ROA11.33
Interest Cover15.99
EBITDA, mln86.26
EV / EBITDA4.79
EV / EBIT5.63
Revenue, mln329
EV / Revenue1.25

Quote Details

Last 51.50
Change 1.5 (3%)
Open 51.50
Volume 0
Turnover 0
Average Volume 15,772

Financial Ratios

Pre-Tax Profit Margin21
Leverage Ratio1.31
Current Ratio4.13
Price / Book1.02
Price / Tangible Book1.11
Price / Cash Flow3.71
Price / Free Cash Flow9.07
Debt / Equity0.05
Price / Sales1.22
PEG Ratio0.71

Financial Strength

Altman Z-Score5.05
Piotroski F-Score 9 / 9
Beneish M-Score-2.62
Price to Intrinsic Value0.60
Price to Lynch Fair Value0.78
Price to Graham Number0.61
Shiller PE Ratio12.33

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.56% 13 / 100   
1 Month -7.47% 18 / 100   
2 Months -2.83% 36 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog